During the past decade, Colorado ENT & Allergy conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 14 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Colorado ENT & Allergy" #1 sponsor was "Aerin Medical" with 4 trials, followed by "Otonomy, Inc." with 4 trials sponsored, "Optinose US Inc." with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Intersect ENT" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Colorado ENT & Allergy" #1 collaborator was "North American Science Associates Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Colorado ENT & Allergy" are "Chronic Rhinitis" (4 trials), "Chronic Rhinosinusitis" (3 trials), "Chronic Sinusitis" (3 trials), "Subjective Tinnitus" (3 trials) and "Nasal Obstruction" (2 trials). Many other conditions were trialed in "Colorado ENT & Allergy" in a lesser frequency.

Most popular intervention types in "Colorado ENT & Allergy" are "Drug" (18 trials), "Device" (9 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Fluticasone Propionate" (2 trials), "Neramexane mesylate" (2 trials), "OTO-313" (2 trials) and "Omalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Colorado ENT & Allergy" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Colorado ENT & Allergy". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Colorado ENT & Allergy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Colorado ENT & Allergy, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".